Literature DB >> 2684071

Snipping the thread of life. Antimuscarinic side effects of medications in the elderly.

N L Peters1.   

Abstract

Drugs with antimuscarinic activity are used for a wide variety of medical conditions. Unfortunately, side effects that develop as a result of muscarinic blockade are common and their frequency and clinical significance appear to increase with advanced age. Nevertheless, such drugs are frequently prescribed to elderly persons, particularly to those living in nursing homes. This review details the prevalence of antimuscarinic drug use in the elderly, the classes of drugs that exhibit antimuscarinic activity, organ-specific effects of muscarinic blockade, side effects identified in elderly individuals, and strategies to prevent or treat complications of antimuscarinic therapy, including recent advances in the development of drugs with selective activity for specific subclasses of muscarinic receptors.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2684071

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  24 in total

1.  The relationship between anticholinergic medications and Mini-Cog scores in older adults receiving home health care.

Authors:  Susan L Lakey; Peggy S Odegard; Travis E Sonnett; Stephen M Setter; Soo Borson
Journal:  Consult Pharm       Date:  2009-09

2.  Analysis of spatiotemporal pattern and quantification of gastrointestinal slow waves caused by anticholinergic drugs.

Authors:  Kelvin K L Wong; Lauren C Y Tang; Jerry Zhou; Vincent Ho
Journal:  Organogenesis       Date:  2017-02-23       Impact factor: 2.500

Review 3.  Adverse events and treatment discontinuations of antimuscarinics for the treatment of overactive bladder in older adults: A systematic review and meta-analysis.

Authors:  Scott Martin Vouri; Clark D Kebodeaux; Paul M Stranges; Besu F Teshome
Journal:  Arch Gerontol Geriatr       Date:  2016-11-14       Impact factor: 3.250

4.  Higher anticholinergic drug scale (ADS) scores are associated with peripheral but not cognitive markers of cholinergic blockade. Cross sectional data from 21 Norwegian nursing homes.

Authors:  Hege Kersten; Espen Molden; Tiril Willumsen; Knut Engedal; Torgeir Bruun Wyller
Journal:  Br J Clin Pharmacol       Date:  2013-03       Impact factor: 4.335

5.  Association of Anticholinergic Drug Burden with Cognitive and Functional Decline Over Time in Older Inpatients: Results from the CRIME Project.

Authors:  Gloria Brombo; Lara Bianchi; Elisa Maietti; Francesca Malacarne; Andrea Corsonello; Antonio Cherubini; Carmelinda Ruggiero; Graziano Onder; Stefano Volpato
Journal:  Drugs Aging       Date:  2018-10       Impact factor: 3.923

Review 6.  Impact of anticholinergic discontinuation on cognitive outcomes in older people: a systematic review.

Authors:  Mohammed Saji Salahudeen; Stephen B Duffull; Prasad S Nishtala
Journal:  Drugs Aging       Date:  2014-03       Impact factor: 3.923

7.  Examination and Estimation of Anticholinergic Burden: Current Trends and Implications for Future Research.

Authors:  Mohammed Saji Salahudeen; Prasad S Nishtala
Journal:  Drugs Aging       Date:  2016-05       Impact factor: 3.923

Review 8.  The problems of anticholinergic adverse effects in older patients.

Authors:  M Feinberg
Journal:  Drugs Aging       Date:  1993 Jul-Aug       Impact factor: 3.923

9.  Secondary psychoses: an update.

Authors:  Matcheri S Keshavan; Yoshio Kaneko
Journal:  World Psychiatry       Date:  2013-02       Impact factor: 49.548

10.  Cumulative anticholinergic exposure is associated with poor memory and executive function in older men.

Authors:  Ling Han; Joseph V Agostini; Heather G Allore
Journal:  J Am Geriatr Soc       Date:  2008-12       Impact factor: 5.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.